Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine

Caroline M. Kopruszinski, Peter Thornton, Joanne Arnold, Philip Newton, David Lowne, Edita Navratilova, Juliana Swiokla, David W. Dodick, Claire Dobson, Ian Gurrell, Iain Patrick Chessell, Frank Porreca

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine'. Together they form a unique fingerprint.

Medicine & Life Sciences